Source: Benzinga

BDSI: BioDelivery Sciences to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019

RALEIGH, N.C., July 30, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI), a specialty pharmaceutical company dedicated to patients living with chronic conditions, today announced its plans to report its second-quarter 2019 financial results after the close of the U.S. financial markets on Thursday, August 8, 2019. The company will host a conference call and webcast at 4:30 PM EDT to discuss the results and provide an update on business operations.Conference Call Dial-In & Webcast Information:Full story available on Benzinga.com

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from BDSI's latest SEC filings

Annual Revenue

Based on data from BDSI's latest SEC filings

Employees

Herm Cukier's photo - CEO of BDSI

CEO

Herm Cukier

CEO Approval Rating

84/100

BioDelivery is a pharmaceutical company that primarily focuses on developing medicines for pain management and addiction... Read more